1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Midnight Pharma, LLC: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia ACT-078573 oral capsules at 25 and 100 mg and matching placebo, ACT-078573 and matching placebo - Chronic Primary Insomnia | Phase 2 | Completed | Midnight Pharma, LLC | 112 | 2007-12-01 | 2016-03-14 |
Sleep Initiation and Maintenance Disorders (1)
almorexant (1)
United States (1)